IP-10 serum levels are not increased in mild cognitive impairment and Alzheimer's disease [2]

European Journal of Neurology

Volumn 14, Issue 4, 2007, Pages

  Galimberti, D ^a   Venturelli, E ^a   Fenoglio, C ^a   Lovati, C ^b   Guidi, I ^a   Scalabrini, D ^a   Mariani, C ^b   Bresolin, N ^a   Scarpini, E ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Alzheimer's disease (AD); Interferon inducible protein 10(IP 10); Mild Cognitive Impairment (MCI)

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10;

AGED; AGING; ALLELE; ALZHEIMER DISEASE; ANALYTIC METHOD; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMENTIA; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; LABORATORY TEST; LETTER; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AGE FACTORS; AGED; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; COGNITION DISORDERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; PYRIMIDINONES; THIAZOLES;

EID: 33947603002     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2006.01637.x     Document Type: Letter

References (7)

1. Galimberti D, Schoonenboom N, Scheltens P, et al. Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer's disease. Archives of Neurology 2006; 63: 538-543.
2. Galimberti D, Schoonenboom N, Scheltens P, et al. Intrathecal chemokine levels in Alzheimer's disease and frontotemporal lobar degeneration. Neurology 2006; 66: 146-147.
3. Guidi I, Galimberti D, Lonati S, et al. Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's disease. Neurobiology of Aging 2006; 27: 262-269.
4. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology 1999; 56: 303-308.
5. Antonelli A, Rotondi M, Fallahi P, et al. Age-dependent changes in CXC chemokine ligand 10 serum levels in euthyroid subjects. Journal of Interferon and Cytokine Research 2005; 25: 547-552.
6. Bruunsgaard H, Pedersen M, Pedersen BK. Aging and proinflammatory cytokines. Current opinion in hematology 2001; 8: 131-136.
7. Devanand DP, Pelton GH, Zamora D, et al. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment. Archives of Neurology 2005; 62: 975-980.